Overseeing research on therapeutic cloning: a private ethics board responds to its critics.: An article from: The Hastings Center Report
Book Details
PublisherHastings Center
ISBN / ASINB0009FMCRA
ISBN-13978B0009FMCR5
MarketplaceIndia 🇮🇳
Description
This digital document is an article from The Hastings Center Report, published by Hastings Center on May 1, 2002. The length of the article is 5161 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
From the author: Advanced Cell Technology's Ethics Advisory Board has been called window dressing for a corporate marketing plan. But the scientists and managers have paid attention, and the lawyers have gone along.
Citation Details
Title: Overseeing research on therapeutic cloning: a private ethics board responds to its critics.
Author: Ronald M. Green
Publication:The Hastings Center Report (Refereed)
Date: May 1, 2002
Publisher: Hastings Center
Volume: 32 Issue: 3 Page: 27(8)
Distributed by Thomson Gale
From the author: Advanced Cell Technology's Ethics Advisory Board has been called window dressing for a corporate marketing plan. But the scientists and managers have paid attention, and the lawyers have gone along.
Citation Details
Title: Overseeing research on therapeutic cloning: a private ethics board responds to its critics.
Author: Ronald M. Green
Publication:The Hastings Center Report (Refereed)
Date: May 1, 2002
Publisher: Hastings Center
Volume: 32 Issue: 3 Page: 27(8)
Distributed by Thomson Gale
